Get my own profile
Public access
View all36 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Terje EspevikProfessor of Cell Biology, NTNUVerified email at ntnu.no
- Jacques NeefjesHoogleraar cell biologie en immunologie, Leiden UniversiteitVerified email at nki.nl
- Jan-Ake GustafssonRobert A. Welch Professor, Department of Biology and Biochemistry, University of HoustonVerified email at central.uh.edu
- Eric O. LongNational Institute of Allergy and Infectious DiseasesVerified email at nih.gov
- Anne SimonsenUniversity of OsloVerified email at medisin.uio.no
- Guttorm HaraldsenProfessor i medisin ved Universitetet i OsloVerified email at rr-research.no
- Nadra J. NilsenNorwegian University of Science and Technology, NTNUVerified email at ntnu.no
- Gerbrand KosterInven2 Technology TransferVerified email at inven2.com
- Jens Preben MorthTechnical University of DenmarkVerified email at dtu.dk
- Mitchell KronenbergLa Jolla Institute for Allergy and ImmunologyVerified email at lji.org
- Gustav GaudernackUltimovacs ASAVerified email at ultimovacs.com
- Jonathan YewdellLaboratory of Viral Diseases, NIAID, NIHVerified email at nih.gov
- Tom Eirik MollnesUiO, NLSHVerified email at medisin.uio.no
- Marie Hjelmseth AuneCenter coordinator at Centre for Digital Life NorwayVerified email at ntnu.no
- Camilla GustafsenAarhus UniversityVerified email at biomed.au.dk
- Thomas HartungChair for Evidence-based Toxicology, Johns Hopkins UniversityVerified email at jhsph.edu
- Mette NyegaardDepartment of Health Science and TechnologyVerified email at hst.aau.dk
- Marit LågNorwegian Institute of Public HealthVerified email at fhi.no
- Meresse StephaneResearcher (DR CNRS)Verified email at ciml.univ-mrs.fr
- Tor GjøenUniversity of OsloVerified email at farmasi.uio.no